GENERAL ATLANTIC, L.P.
New York, NY · CIK 1017645 · 13F filing filed 2025-08-14
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entityGENERAL ATLANTIC, L.P. (US)
- Others nearbyNew York, NY
Holdings, Q2 2025
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| DLOCAL LTD DLO | $724.7m19.97% | Unchanged |
| CHIME FINL INC CHYM | $662.9m18.26% | New |
| ALIGNMENT HEALTHCARE INC ALHC | $615.9m16.97% | Reduced -17.0m |
| XP INC XP | $515.5m14.20% | Reduced -4.1m |
| AKERO THERAPEUTICS INC AKRO | $306.0m8.43% | Added +500.0k |
| ALKAMI TECHNOLOGY INC ALKT | $290.7m8.01% | Unchanged |
| PHARVARIS N V PHVS | $132.6m3.65% | Unchanged |
| CENTESSA PHARMACEUTICALS PLC SPONSORED ADS | $127.2m3.51% | Unchanged |
| WEBULL CORP BULL | $85.5m2.36% | New |
| EUROPEAN WAX CTR INC EWCZ | $73.8m2.03% | Unchanged |
| ROYALTY PHARMA PLC RPRX | $54.0m1.49% | Unchanged |
| RISKIFIED LTD RSKD | $26.6m0.73% | Unchanged |
| ADAGENE INC ADAG | $7.5m0.21% | Unchanged |
| ALUMIS INC ALMS | $3.9m0.11% | New |
| GROVE COLLABORATIVE HOLD INC GROV | $2.8m0.08% | Unchanged |
Sold out since Q1 2025
| Security | Value then |
|---|---|
| IMMUNOCORE HLDGS PLC IMCR | $37.4m1.3m shares |
| ACELYRIN INC | $6.7m2.7m shares |
| CONTEXTLOGIC INC LOGC | $4.3m609.6k shares |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| DLOCAL LTD DLO · 13D · filed 2026-08-19 | 21.4%≈ $478.4m |
| ALKAMI TECHNOLOGY INC ALKT · 13D · filed 2026-05-15 | 18.1%≈ $351.9m |
| LIFTOFF MOBILE INC LFTO · 13D · filed 2026-06-12 | 15.0%≈ $608.1m |
| SEAPORT THERAPEUTICS INC SPTX · 13D · filed 2026-05-11 | 11.5%≈ $132.5m |
| AKERO THERAPEUTICS INC AKRO · 13G · filed 2025-05-15 | 8.4% |
| PHARVARIS N V PHVS · 13G · filed 2026-08-14 | 7.6%≈ $185.3m |
| CHIME FINL INC CHYM · 13G · filed 2025-11-10 | 5.6%≈ $393.4m |
| XP INC XP · 13D · filed 2025-12-04 | 5.4%≈ $370.1m |
Trades reported as a company insider in Q2 2025
Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.
| Date | Company | Trade | Value |
|---|---|---|---|
| 2025-05-19 | ALIGNMENT HEALTHCARE INC Director · See footnote | Sold | $259.8m17.0m shares |